Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Kristen M. O'Dwyer"'
Autor:
Bijal Shah, Ryan D. Cassaday, Jae H. Park, Roche Houot, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Kristen M. O’dwyer, Maria R. Baer, Gary J. Schiller, Mehrdad Abedi, Monique C. Minnema, Patrick Stiff, Lang Zhou, Tsveta Hadjivassileva, Rita Damico Khalid, Armin Ghobadi
Publikováno v:
HemaSphere, Vol 7, p e54499e3 (2023)
Externí odkaz:
https://doaj.org/article/7aed547152154c0faf9b4f2f5e348358
Autor:
Bijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-11 (2022)
Abstract Background Brexucabtagene autoleucel (KTE-X19) is an autologous anti-CD19 CAR T-cell therapy approved in the USA to treat adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL) based on ZUMA-3 study r
Externí odkaz:
https://doaj.org/article/c6f5581c75904c159d9b64a730068459
Autor:
Kristen M, O'Dwyer
Publikováno v:
Hematology Am Soc Hematol Educ Program
T-lineage acute lymphoblastic leukemia (T-ALL) is curable for most children and adolescent and young adult patients with contemporary frontline chemotherapy regimens. During the past decade, improved survival rates have resulted from the optimization
Autor:
Tarun Bhagnani, Jian J. Zhu, David Robert R. Freyer, Kristen M. O'Dwyer, Michael E. Roth, Julie A. Wolfson, Qian Meng, Rui Sammi Tang, Robert G. Paglia
Publikováno v:
Blood. 140:2190-2192
Autor:
Jozal W. Moore, Jason H. Mendler, Kah Poh (melissa) Loh, Mitra Azadniv, Kristen M. O'Dwyer, Eric J. Huselton, Frank Akwaa, Benjamin J. Frisch, Myla Strawderman, Mark W. LaMere, Daniel K. Byun, Alyssa C. Jasper, Michael W. Becker, Jane L. Liesveld, Laura M. Calvi
Publikováno v:
Blood. 140:4050-4052
Autor:
Anjali S. Advani, Anna Moseley, Kristen M. O'Dwyer, Brent L. Wood, Min Fang, Matthew J. Wieduwilt, Ibrahim Aldoss, Jae H. Park, Rebecca B. Klisovic, Maria R. Baer, Wendy Stock, Rupali R. Bhave, Megan Othus, Richard C. Harvey, Cheryl L. Willman, Mark R. Litzow, Richard M. Stone, Elad Sharon, Harry P. Erba
Publikováno v:
J Clin Oncol
PURPOSE Chemotherapy outcomes in older patients with Philadelphia (Ph) chromosome–negative B-acute lymphoblastic leukemia (ALL) are very poor. Here, we evaluated blinatumomab as induction and consolidation therapy followed by prednisone, vincristin
Autor:
Jozal W. Moore, Kristen M. O’Dwyer
Publikováno v:
The Hematologist. 20
Autor:
Anjali S. Advani, Anna Moseley, Kristen M. O’Dwyer, Brent L. Wood, Jae Park, Matthew Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L. Atallah, Aaron T. Gerds, Susan M. O'Brien, Jane L. Liesveld, Megan Othus, Mark Litzow, Richard M. Stone, Elad Sharon, Harry P. Erba
Publikováno v:
Blood Adv
Blood advances, vol 7, iss 7
Blood advances, vol 7, iss 7
Novel treatment strategies are needed for the treatment of Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL) in older patients. This trial evaluated the feasibility and outcomes with the anti-CD19 bispecific T-cell–engagin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15024d0b3f2b90820c17cf3628dca6c3
https://europepmc.org/articles/PMC10090098/
https://europepmc.org/articles/PMC10090098/
Autor:
Bijal D. Shah, Ryan D. Cassaday, Jae H. Park, Roch Houot, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Behzad Kharabi Masouleh, Armin Ghobadi
Publikováno v:
Transplantation and Cellular Therapy. 29:S7-S8
Autor:
Deepa Jeyakumar, Ryan D. Cassaday, Roch Houot, Chaoling Feng, Dimitrios Tzachanis, Maria R. Baer, John M. Rossi, Patrick J. Stiff, Marion Subklewe, Max S. Topp, Behzad Kharabi Masouleh, Bijal D. Shah, Remus Vezan, Martha Arellano, Olalekan O. Oluwole, Aaron C Logan, William G. Wierda, Kristen M. O'Dwyer, Tong Shen, Monique C. Minnema, Jinghui Dong, Daniel J. DeAngelo, Nicolas Boissel, Mehrdad Abedi, Francesca Milletti, Gary J. Schiller, Thibaut Leguay, Armin Ghobadi, Michael R. Bishop, Yi Lin, Jae H. Park
Publikováno v:
Lancet
Lancet, Elsevier, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
The Lancet
The Lancet, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
Lancet, Elsevier, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
The Lancet
The Lancet, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
International audience; BACKGROUND: Despite treatment with novel therapies and allogeneic stem-cell transplant (allo-SCT) consolidation, outcomes in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia remain poor, und